Center for General Practice at Aalborg University, Aalborg, Denmark.
Department of Sports Science and Clinical Biomechanics, Research Unit for Musculoskeletal Function and Physiotherapy, University of Southern Denmark, Odense, Denmark.
Scand J Pain. 2021 Dec 3;22(3):543-551. doi: 10.1515/sjpain-2021-0121. Print 2022 Jul 26.
The prevalence of pain medication use for adolescent knee pain and factors associated with use are not well understood. This study aimed to determine the self-reported use of pain medication for knee pain and identify factors associated with use in adolescents (age 10-19) with longstanding knee symptoms.
In this exploratory cross-sectional study, we performed a secondary analysis of data previously collected in 323 adolescents with longstanding knee pain. Factors associated with pain medication use were assessed using multivariable logistic regressions. Analyses were repeated with stratification by age, sex, sport participation frequency, knee pain duration, and knee pain intensity.
Among 323 adolescents (mean age 14.4 ± 2.5, 73% female), 84% had patellofemoral pain, (peri- or retro-patellar pain during loaded bending of the knee) and 16% had Osgood-Schlatter Disease (apophysitis with swelling and localized pain at the tibial tuberosity). Twenty-one percent (95% CI 16-25%) of adolescents reported pain medication use for their knee pain, with no difference in usage between those ≤ vs. > 15 years of age (21%, 95% CI 16-27% vs. 20%, 95% CI 13-29%). Adolescents with patellofemoral pain reported greater usage than their counterparts with Osgood-Schlatter Disease (22%, 95% CI 17-28% vs. 12%, 95% CI 4.5-24.3%). The most consistent factor associated with use was knee-related symptoms, observed in both the overall (OR 0.97, 95% CI 0.94-0.99) and stratified analyses (ORs ranged from 0.89 to 0.96).
Approximately one in five adolescents with longstanding knee pain reported pain medication use, particularly in adolescents with patellofemoral pain. Knee-related symptoms most consistently associated with the use of pain medications in this population. Future longitudinal studies with data collected at multiple time-points are needed to validate these findings.
Self-reported pain medication use is common in adolescents with longstanding knee pain, even though whether pharmacological therapy is the best pain management option at this young age is debatable. Reliance on pain medication at an early age could potentially hamper the development of healthy pain coping strategies and increase the risk of dependence and misuse later in life. Future studies should assess the safety, efficacy, and risks of long-term use of pain medications for adolescent knee pain.
青少年膝关节疼痛药物使用的流行情况及其相关因素尚不清楚。本研究旨在确定长期膝关节症状的青少年(10-19 岁)自我报告的膝关节疼痛药物使用情况,并确定与使用相关的因素。
在这项探索性横断面研究中,我们对先前在 323 名长期膝关节疼痛的青少年中收集的数据进行了二次分析。使用多变量逻辑回归评估与疼痛药物使用相关的因素。对年龄、性别、运动参与频率、膝关节疼痛持续时间和膝关节疼痛强度分层后,重复了分析。
在 323 名青少年(平均年龄 14.4±2.5 岁,73%为女性)中,84%患有髌股疼痛(膝关节负重弯曲时出现髌前或髌后疼痛),16%患有 Osgood-Schlatter 病(胫骨结节处的附着炎伴肿胀和局部疼痛)。21%(95%CI 16-25%)的青少年报告因膝关节疼痛使用止痛药,年龄≤15 岁和>15 岁的使用情况无差异(21%,95%CI 16-27% vs. 20%,95%CI 13-29%)。髌股疼痛的青少年比 Osgood-Schlatter 病患者报告的使用率更高(22%,95%CI 17-28% vs. 12%,95%CI 4.5-24.3%)。与使用相关的最一致的因素是膝关节相关症状,在总体(OR 0.97,95%CI 0.94-0.99)和分层分析中均观察到(OR 范围为 0.89-0.96)。
大约五分之一的长期膝关节疼痛的青少年报告使用止痛药,特别是在髌股疼痛的青少年中。膝关节相关症状与该人群使用止痛药最密切相关。需要未来进行具有多个时间点数据收集的纵向研究来验证这些发现。
尽管在这个年轻的年龄阶段,药物治疗是否是治疗青少年膝关节疼痛的最佳疼痛管理方法仍存在争议,但长期膝关节疼痛的青少年中自我报告的止痛药使用很常见。年轻时依赖止痛药可能会阻碍健康的疼痛应对策略的发展,并增加日后依赖和滥用的风险。未来的研究应该评估青少年膝关节疼痛长期使用止痛药的安全性、有效性和风险。